Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 731

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 7
Chunk 731
---
5,064,955)
  
    Total stockholders’ equity 
     2,878,571  
     4,013,211 

    Total liabilities and stockholders’ equity 
    $3,679,332  
    $4,923,283 

See
accompanying notes to audited financial statements.

F-3

SYRA
HEALTH CORP.

STATEMENTS
OF OPERATIONS

    2024  
    2023 

    For the Year Ended 

    2024  
    2023 

    Net revenues 
    $7,982,082  
    $5,515,144 
  
    Cost of services 
     6,329,119  
     4,103,244 
  
    Gross profit 
     1,652,963  
     1,411,900 

    Operating expenses: 

    Salaries and benefits 
     2,718,743  
     2,292,295 
  
    Professional services 
     606,051  
     586,463 
  
    Research and development expenses 
     585,146  
     240,048 
  
    Selling, general and administrative expenses 
     1,445,170  
     1,131,922 
  
    Depreciation 
     62,738  
     48,771 
  
    Total operating expenses 
     5,417,848  
     4,299,499 

    Operating loss 
     (3,764,885) 
     (2,887,599)

    Other income (expense): 

    Interest income 
     21,247  
     2,942 
  
    Interest expense 
     (15,600) 
     (53,686)
  
    Total other income (expense) 
     5,647  
     (50,744)

    Net loss 
    $(3,759,238) 
    $(2,938,343)

    Weighted average common shares outstanding - basic and diluted 
     7,551,576  
     4,877,861 
  
    Net loss per common share - basic and diluted 
    $(0.50) 
    $(0.60)

See
accompanying notes to audited financial statements.

F-4

SYRA
HEALTH COR